Bath & Body Works, Inc.

Bath & Body Works trades at a remarkably compressed 5.96 P/E—less than one-third the consumer cyclical median—despite neutral RSI of 49.0 and no proximity to 52-week highs. This valuation discount suggests the market prices in persistent headwinds, whether structural retail challenges, margin pressure, or sluggish traffic. With $3.9B market cap, the stock appears genuinely cheap on earnings multiples, yet that cheapness may reflect legitimate concerns about competitive positioning or demand sustainability. The lack of overbought conditions and distance from yearly peaks indicate limited near-term momentum, raising questions about whether the valuation is a trap or a genuine opportunity obscured by cyclical weakness.